Literature DB >> 6501809

The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.

M Anastasiou-Nana, D A Koutras, G Levis, A Souvatzoglou, M A Boukis, S D Moulopoulos.   

Abstract

Amiodarone, a widely used iodine-containing antiarrhythmic drug, has been shown to divert the peripheral metabolism of T4 towards rT3 than T3. In this prospective study we correlated the concentration of the peripheral thyroid hormones in serum with that of amiodarone. Fifteen euthyroid volunteers were studied, 5 men and 10 women, with a mean age of 64.2 yr, who suffered from various cardiac arrhythmias (atrial fibrillation or multiple ventricular extrasystoles). Serum amiodarone, T4, T3, rT3 and TSH were determined before and 3, 7, and 14 days after the administration of 400-600 mg amiodarone/day. There was a small increase in serum T4 and a suggestive decrease in serum T3. The increase in serum rT3 was significant, with p less than 0.05 for 3 days, p less than 0.01 for 7 days and p less than 0.005 for 14 days. There was a significant correlation between the level of serum amiodarone and the rise in serum rT3 (r = 0.385, p less than 0.05). The rise in rT3 is the main thyroid abnormality after amiodarone administration and may be used as a rough index of the serum concentration of this drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501809     DOI: 10.1007/BF03351026

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent.

Authors:  D A Koutras; J Malamitsi; A Souvatzoglou; G D Piperingos; D P Livadas; M Boukis; D N Papachristou; J Sfontouris; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

2.  Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism?

Authors:  M J Lambert; A G Burger; R L Galeazzi; D Engler
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

3.  Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors:  M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

4.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

5.  Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.

Authors:  K Nademanee; B N Singh; J A Hendrickson; A W Reed; S Melmed; J Hershman
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

6.  Pharmacokinetics of amiodarone after intravenous and oral administration.

Authors:  M Anastasiou-Nana; G M Levis; S Moulopoulos
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-11

7.  Metabolic insufficiency as a limiting factor in the dietetic treatment of obesity.

Authors:  J Kitsopanides; D A Koutras; A Souvatzoglou; M Boukis; G D Piperingos; J Sfontouris; S D Moulopoulos
Journal:  Horm Metab Res       Date:  1981-09       Impact factor: 2.936

8.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.

Authors:  S Melmed; K Nademanee; A W Reed; J A Hendrickson; B N Singh; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  Effect of amiodarone on L-triiodothyronine stimulation of [3H] thymidine incorporation into GH3 cells.

Authors:  I D Goldfine; B Maddux; K A Woeber
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

10.  Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.

Authors:  J J Heger; E N Prystowsky; W M Jackman; G V Naccarelli; K A Warfel; R L Rinkenberger; D P Zipes
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

View more
  5 in total

1.  Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents.

Authors:  R Schindler
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

2.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

3.  The effect of benziodarone on the thyroid hormone levels and the pituitary-thyroid axis.

Authors:  B Xanthopoulos; D A Koutras; M A Boukis; G D Piperingos; J Kitsopanides; A Souvatzoglou; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

4.  Effect of amiodarone on serum T4 and T3 levels in hyperthyroid patients treated with methimazole.

Authors:  O Van Reeth; C Decoster; J Unger
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Therapeutic monitoring of amiodarone and desethylamiodarone after surgical ablation of atrial fibrillation-evaluation of the relationship between clinical effect and the serum concentration.

Authors:  Erika Hrudikova; Milan Grundmann; Martin Kolek; Romana Urinovska; Ivana Kacirova
Journal:  Saudi Pharm J       Date:  2021-03-31       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.